NKTR News

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Aquestive Therapeutics, Inc. (AQST), Nektar Therapeutics (NKTR), and Eos Energy Enterprises, Inc. (EOSE) Announced by Holzer & Holzer, LLC

NKTR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Moves to File Class Action Against Nektar Therapeutics – NKTR

Faruqi & Faruqi, LLP Highlights Class Action Against Nektar Therapeutics (NKTR) and Upcoming Lead Plaintiff Deadline of May 5, 2026 Ready to Announce with Confidence?

Nektar Therapeutics (NKTR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misleading Institutional Shareholders: Levi & Korsinsky

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm

Portnoy Law Firm Announces Class Action on Behalf of Nektar Therapeutics, Inc. Investors

NKTR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Pursues Class Action Lawsuit Against Nektar Therapeutics – NKTR